Who founded NaluBio, Inc.?

NaluBio, Inc. was founded by Caitlyn Krebs, Phyllis Whiteley, Randall Ussery in 2019.

Who are NaluBio, Inc.'s investors?

NaluBio, Inc.'s investors include Bonaventure Equity, LLC, Flybridge Capital Partners, Portfolia, Golden Seeds, xfactor ventures.

How much funding has NaluBio, Inc. raised?

NaluBio, Inc. has disclosed $4.8M raised across 1 round.

Where is NaluBio, Inc. headquartered?

NaluBio, Inc. is headquartered in San Francisco, US.

NaluBio, Inc.

San Francisco, US · Founded 2019 · Delaware corporation · 14 employees on LinkedIn · 5 known investors

Find your way into NaluBio, Inc.

Paths you didn't know you had: your email and LinkedIn already hold routes to the NaluBio, Inc. team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases. The company designs novel, non-addictive ECS-based solutions for patients with conditions like chronic pain, sleep disorders, and endometriosis.

AI & Machine Learning Biotech Healthtech Medical Devices

Founders & leadership

NaluBio, Inc. was founded in 2019 by Caitlyn Krebs, Phyllis Whiteley, and Randall Ussery.

Caitlyn Krebs Co-founder + CEOCaitlyn Krebs is co-founder and CEO of Nalu Bio, an AI-powered drug discovery company developing therapeutics for inflammatory, immune, and metabolic diseases including chronic pain, sleep disorders, and endometriosis. She has held leadership roles at multiple biotech companies spanning AI-driven drug discovery, diabetes prevention, Alzheimer's detection, and cancer diagnostics over the past 20+ years.

Phyllis Whiteley Co-founder + Board MemberPhyllis Whiteley holds a BA in Chemistry and PhD in Pharmacology from Washington University in St. Louis. She has held executive and board roles across venture capital, biotech, and pharma, including positions at Roche, Perlegen, Merck, and MDV, where she helped build companies including Verinata Health (acquired by Illumina), and previously co-founded Anaphore with 5AM Ventures.

Randall UsseryCo-founder + Board Member

Howard GoodwinNamed on SEC filing

Investors · 5

Bonaventure Equity, LLClisted by Bonaventure Equity, LLCRaleigh

How we know: Bonaventure Equity, LLC's portfolio page · Not right? Tell us

Flybridge Capital Partnerslisted by Flybridge Capital PartnersNew York · $250K – $10M

How we know: Flybridge Capital Partners's portfolio page · the VCSheet dataset · Not right? Tell us

Portfolialisted by PortfoliaSan Mateo

How we know: the VCSheet dataset · Not right? Tell us

Golden SeedsreportedFlushing · $250K – $2M

How we know: the VCSheet dataset · Not right? Tell us

xfactor venturesreportedDedham · $100K – $200K

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$4.8M disclosed across 1 round · 2023

▶$4.8MraisedMar 2023 · 11 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Phyllis E. WhiteleyExecutive Officer, Director
Howard GoodwinDirector
Randall S. UsseryDirector
Caitlyn KrebsExecutive Officer, Director

Offering amount: $17.1M
Amount sold: $4.8M
First sale: Jan 2023
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

NaluNalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain. The system consists of an implanted microstimulator, a separate electrode array, and an externally worn, battery-free therapy disc, offered as a drug-free treatment option to patients through their doctors.

Companies working in the same space as NaluBio, Inc..

Frequently asked questions

What does NaluBio, Inc. do?: Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases. The company designs novel, non-addictive ECS-based solutions for patients with conditions like chronic pain, sleep disorders, and endometriosis.
Who founded NaluBio, Inc.?: NaluBio, Inc. was founded by Caitlyn Krebs, Phyllis Whiteley, Randall Ussery in 2019.
Who are NaluBio, Inc.'s investors?: NaluBio, Inc.'s investors include Bonaventure Equity, LLC, Flybridge Capital Partners, Portfolia, Golden Seeds, xfactor ventures.
How much funding has NaluBio, Inc. raised?: NaluBio, Inc. has disclosed $4.8M raised across 1 round.
Where is NaluBio, Inc. headquartered?: NaluBio, Inc. is headquartered in San Francisco, US.